FDA Inspection 1163408 — Oklahoma Blood Institute
The FDA completed an inspection of Oklahoma Blood Institute on February 16, 2022 in Fort Smith, AR. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 16, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Fort Smith, AR (United States)